REVLIMID REMS Trademark

Trademark Overview


On Wednesday, April 3, 2013, a trademark application was filed for REVLIMID REMS with the United States Patent and Trademark Office. The USPTO has given the REVLIMID REMS trademark a serial number of 85894356. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 7, 2024. This trademark is owned by Celgene Corporation. The REVLIMID REMS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Programs in the nature of providing medical counseling and medical information in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide, and providing medical information in the aforementioned fields by distributing written materials in connection therewith
revlimid rems

General Information


Serial Number85894356
Word MarkREVLIMID REMS
Filing DateWednesday, April 3, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 7, 2024
Registration Number4439525
Registration DateTuesday, November 26, 2013
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 10, 2013

Trademark Statements


Description of MarkThe mark consists of "REVLIMID" in blue and "REMS" in yellow.
Pseudo MarkREVLIMID REMS
Indication of Colors claimedThe color(s) blue and yellow is/are claimed as a feature of the mark.
Goods and ServicesPrograms in the nature of providing medical counseling and medical information in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide, and providing medical information in the aforementioned fields by distributing written materials in connection therewith
NOT AVAILABLE"REMS"

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 7, 2024
Primary Code044
First Use Anywhere DateFriday, January 11, 2013
First Use In Commerce DateFriday, January 11, 2013

Trademark Owner History


Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events


Event DateEvent Description
Thursday, April 11, 2013NOTICE OF PSEUDO MARK E-MAILED
Tuesday, July 16, 2013ASSIGNED TO EXAMINER
Friday, July 19, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 6, 2013NEW APPLICATION ENTERED
Wednesday, April 10, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 19, 2013NON-FINAL ACTION WRITTEN
Friday, July 19, 2013NON-FINAL ACTION E-MAILED
Friday, July 19, 2013EXAMINER'S AMENDMENT ENTERED
Friday, July 19, 2013EXAMINERS AMENDMENT -WRITTEN
Friday, July 19, 2013EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 19, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 10, 2013PUBLISHED FOR OPPOSITION
Tuesday, September 10, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 26, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 26, 2018TEAS SECTION 8 & 15 RECEIVED
Friday, August 2, 2013ASSIGNED TO LIE
Wednesday, August 7, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 21, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 26, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, December 20, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, November 26, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, June 7, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Thursday, December 20, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, December 20, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.